Can Protein Translation be Targeted for Cancer Therapy?
Yes, targeting protein translation offers a promising strategy for cancer therapy. Several approaches are being explored:
Small molecule inhibitors that target translation initiation factors Drugs that inhibit the mTOR pathway RNA-based therapies that modulate the expression of translation-regulating microRNAs
These strategies aim to reduce the synthesis of proteins that are essential for cancer cell survival and proliferation.
